|
|
||||||||
Division of Pharmacology/Neurobiology, Biozentrum of the University of Basel, Basel, Switzerland
Induction of drug metabolism was described more than 40 years ago. Progress in understanding the molecular mechanism of induction of drug-metabolizing enzymes was made recently when the important roles of the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), two members of the nuclear receptor superfamily of transcription factors, were discovered to act as sensors for lipophilic xenobiotics, including drugs. CAR and PXR bind as heterodimeric complexes with the retinoid X receptor to response elements in the regulatory regions of the induced genes. PXR is directly activated by xenobiotic ligands, whereas CAR is involved in a more complex and less well understood mechanism of signal transduction triggered by drugs. Most recently, analysis of these xenobiotic-sensing nuclear receptors and their nonmammalian precursors such as the chicken xenobiotic receptor suggests an important role of PXR and CAR also in endogenous pathways, such as cholesterol and bile acid biosynthesis and metabolism. In this review, recent findings regarding xenosensors and their target genes are summarized and are put into an evolutionary perspective in regard to how a living organism has derived a system that is able to deal with potentially toxic compounds it has not encountered before.
Abstract I. Introduction II. Drug-Mediated Induction of Cytochromes P450 A. Induction of CYP2Bs, CYP2Cs, and CYP3As by Drugs and Xenobiotics III. Drug-Response Elements in Inducible Cytochrome P450 Genes A. CYP102/106 in Bacillus megaterium B. CYP6 in Insects C. CYP2H1/2, CYP3A37, and CYP2C45 in Chicken D. CYP2Bs, CYP3As, and CYP2Cs in Mammals E. Other Mammalian Drug-Inducible Cytochromes P450 IV. Nuclear Receptors Involved in Drug Induction of Cytochromes P450 A. Constitutive Androstane Receptor B. Pregnane X Receptor C. The Evolution of Xenosensors: Lessons Learned from the Chicken Xenobiotic Receptor D. Structure of the Xenosensors E. Other Target Genes of Pregnane X Receptor and Constitutive Androstane Receptor V. Endogenous Roles of the Xenosensors A. Receptor Cross Talk in Hepatic Drug Induction VI. Clinical Relevance of Induction A. Altered Kinetics of Drugs B. Genetic Variants of Pregnane X Receptor and Constitutive Androstane Receptor VII. Open Questions A. Mechanisms of Constitutive Androstane Receptor Translocation and Activation B. Cofactors Involved in Pregnane X Receptor- and Constitutive Androstane Receptor-Mediated Signal Transduction C. The Xenosensors as Drug Targets D. The Mystery of How Cells Recognize Phenobarbital-Type Inducers VIII. Outlook
This article has been cited by other articles:
![]() |
Y. Xie, S. Ke, N. Ouyang, J. He, W. Xie, M. T. Bedford, and Y. Tian Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1 J. Biol. Chem., April 3, 2009; 284(14): 9199 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, S. Coulter, A. M. Jetten, and J. A. Goldstein Identification of Human CYP2C8 as a Retinoid-Related Orphan Nuclear Receptor Target Gene J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 192 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Audet-Walsh and A. Anderson Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor Drug Metab. Dispos., March 1, 2009; 37(3): 580 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Murphy The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 3, 1984-2008 Drug Metab. Dispos., October 1, 2008; 36(10): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, W. W. Prosise, J. Chen, S. S. Taremi, H. V. Le, V. Madison, X. Cui, A. Thomas, K.-C. Cheng, and C. A. Lesburg Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability Protein Eng. Des. Sel., July 1, 2008; 21(7): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Rosen, B. D. Abbott, D. C. Wolf, J. C. Corton, C. R. Wood, J. E. Schmid, K. P. Das, R. D. Zehr, E. T. Blair, and C. Lau Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid Toxicol Pathol, June 1, 2008; 36(4): 592 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Morey, J. C. Ryan, M.-Y. Bottein Dechraoui, A. H. Rezvani, E. D. Levin, C. J. Gordon, J. S. Ramsdell, and F. M. Van Dolah Liver Genomic Responses to Ciguatoxin: Evidence for Activation of Phase I and Phase II Detoxification Pathways following an Acute Hypothermic Response in Mice Toxicol. Sci., June 1, 2008; 103(2): 298 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roth, R. Looser, M. Kaufmann, S. M. Blattler, F. Rencurel, W. Huang, D. D. Moore, and U. A. Meyer Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression Mol. Pharmacol., April 1, 2008; 73(4): 1282 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Healan-Greenberg, J. F. Waring, D. J. Kempf, E. A. G. Blomme, R. G. Tirona, and R. B. Kim A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor Drug Metab. Dispos., March 1, 2008; 36(3): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti and C. D. Klaassen Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 612 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gehlhaus, N. Schmitt, B. Volk, and R. P. Meyer Antiepileptic Drugs Affect Neuronal Androgen Signaling via a Cytochrome P450-Dependent Pathway J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 550 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Blattler, F. Rencurel, M. R. Kaufmann, and U. A. Meyer In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase PNAS, January 16, 2007; 104(3): 1045 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Nelson, V. Bhaskaran, W. R. Foster, and L. D. Lehman-McKeeman p53-Independent Induction of Rat Hepatic Mdm2 following Administration of Phenobarbital and Pregnenolone 16{alpha}-Carbonitrile Toxicol. Sci., December 1, 2006; 94(2): 272 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, M.-L. Noordine, C. Cherbuy, P. Vaugelade, J. M. Pascussi, P.-H. Duee, and M. Thomas Different activation patterns of rat xenobiotic metabolism genes by two constituents of garlic Carcinogenesis, October 1, 2006; 27(10): 2090 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Corbett, K. B. Patterson, H.-C. Tien, L. A. Kalvass, J. J. Eron, L. T. Ngo, M. L. Lim, and A. D. M. Kashuba Dose Separation Does Not Overcome the Pharmacokinetic Interaction between Fosamprenavir and Lopinavir/Ritonavir. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2756 - 2761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jung, D. J. Mangelsdorf, and U. A. Meyer Pregnane X Receptor Is a Target of Farnesoid X Receptor J. Biol. Chem., July 14, 2006; 281(28): 19081 - 19091. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gu, S. Ke, D. Liu, T. Sheng, P. E. Thomas, A. B. Rabson, M. A. Gallo, W. Xie, and Y. Tian Role of NF-{kappa}B in Regulation of PXR-mediated Gene Expression: A MECHANISM FOR THE SUPPRESSION OF CYTOCHROME P-450 3A4 BY PROINFLAMMATORY AGENTS J. Biol. Chem., June 30, 2006; 281(26): 17882 - 17889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Baldwin, J. L. Bramhall, C. A. Ashby, L. Yue, P. R. Murdock, S. R. Hood, A. D. Ayrton, and S. E. Clarke CYTOCHROME P450 GENE INDUCTION IN RATS EX VIVO ASSESSED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (TAQMAN) Drug Metab. Dispos., June 1, 2006; 34(6): 1063 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Faucette, T. Sueyoshi, C. M. Smith, M. Negishi, E. L. LeCluyse, and H. Wang Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1200 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kourylko, C. Fradette, M. Arcand, and P. du Souich MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6 Drug Metab. Dispos., January 1, 2006; 34(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Vyhlidal, R. Gaedigk, and J. S. Leeder NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION Drug Metab. Dispos., January 1, 2006; 34(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aouabdi, G. Gibson, and N. Plant TRANSCRIPTIONAL REGULATION OF THE PXR GENE: IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {alpha} BINDING SITE WITHIN THE PROXIMAL PROMOTER OF PXR Drug Metab. Dispos., January 1, 2006; 34(1): 138 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Auerbach, M. A. Stoner, S. Su, and C. J. Omiecinski Retinoid X Receptor-{alpha}-Dependent Transactivation by a Naturally Occurring Structural Variant of Human Constitutive Androstane Receptor (NR1I3) Mol. Pharmacol., November 1, 2005; 68(5): 1239 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gnerre, G. U. Schuster, A. Roth, C. Handschin, L. Johansson, R. Looser, P. Parini, M. Podvinec, K. Robertsson, J.-A. Gustafsson, et al. LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver J. Lipid Res., August 1, 2005; 46(8): 1633 - 1642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wyde, S. E. Kirwan, F. Zhang, A. Laughter, H. B. Hoffman, E. Bartolucci-Page, K. W. Gaido, B. Yan, and L. You Di-n-Butyl Phthalate Activates Constitutive Androstane Receptor and Pregnane X Receptor and Enhances the Expression of Steroid-Metabolizing Enzymes in the Liver of Rat Fetuses Toxicol. Sci., August 1, 2005; 86(2): 281 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mohutsky, D. M. Petullo, and S. A. Wrighton THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES Drug Metab. Dispos., July 1, 2005; 33(7): 920 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Burk, K. A. Arnold, A. K. Nussler, E. Schaeffeler, E. Efimova, B. A. Avery, M. A. Avery, M. F. Fromm, and M. Eichelbaum Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor Mol. Pharmacol., June 1, 2005; 67(6): 1954 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tang, J. H. Lin, and A. Y. H. Lu METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION? Drug Metab. Dispos., May 1, 2005; 33(5): 603 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li and J. Y. L. Chiang Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7{alpha}-hydroxylase gene transcription Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G74 - G84. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bi and P. K. Rogan Bipartite pattern discovery by entropy minimization-based multiple local alignment Nucleic Acids Res., September 23, 2004; 32(17): 4979 - 4991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes Mol. Cell. Biol., September 15, 2004; 24(18): 7931 - 7940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice J. Biol. Chem., May 21, 2004; 279(21): 22250 - 22257. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |